Antitumor Activity of Novel Pyrazole-Based Small Molecular Inhibitors of the STAT3 Pathway in Patient Derived High Grade Glioma Cells

PLoS ONE - United States
doi 10.1371/journal.pone.0220569
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

The Isoprenoid Derivative N6 -Benzyladenosine CM223 Exerts Antitumor Effects in Glioma Patient-Derived Primary Cells Through the Mevalonate Pathway

British Journal of Pharmacology
Pharmacology
2017English

Antitumor Activity of a Novel Oral STAT3 Inhibitor YHO‐1701

Cancer Science
Cancer ResearchMedicineOncology
2020English

Antitumor Activity of Histone Deacetylase Inhibitors in Non-Small Cell Lung Cancer Cells: Development of a Molecular Predictive Model

Molecular Cancer Therapeutics
Cancer ResearchOncology
2008English

Combination of PI3K/mTOR Inhibitors: Antitumor Activity and Molecular Correlates

Cancer Research
Cancer ResearchOncology
2011English

Synergistic Antitumor Effects of Berbamine and Paclitaxel Through ROS/Akt Pathway in Glioma Cells

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2017English

2-Guanidinoquinazolines as New Inhibitors of the STAT3 Pathway

Bioorganic and Medicinal Chemistry Letters
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2014English

Next Generation CAR T Cells for the Immunotherapy of High-Grade Glioma

Frontiers in Oncology
Cancer ResearchOncology
2019English

A Novel Dual PI3Kα/mTOR Inhibitor PI-103 With High Antitumor Activity in Non-Small Cell Lung Cancer Cells

International Journal of Molecular Medicine
MedicineGenetics
2009English

The Novel ATM Inhibitor (AZ31) Enhances Antitumor Activity in Patient Derived Xenografts That Are Resistant to Irinotecan Monotherapy

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy